Synopsys, Inc. (NASDAQ:SNPS) Given Consensus Rating of “Hold” by Brokerages

Shares of Synopsys, Inc. (NASDAQ:SNPSGet Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and nine have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have issued ratings on the stock in the last year is $563.8125.

Several equities analysts have commented on SNPS shares. BNP Paribas Exane upped their price objective on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Robert W. Baird set a $558.00 price objective on shares of Synopsys in a report on Thursday, May 28th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Synopsys in a report on Monday, June 8th. HSBC downgraded shares of Synopsys from a “buy” rating to a “hold” rating and set a $455.00 price objective on the stock. in a report on Friday, February 20th. Finally, Wells Fargo & Company upped their price objective on shares of Synopsys from $505.00 to $535.00 and gave the company an “equal weight” rating in a report on Thursday, May 28th.

Check Out Our Latest Report on SNPS

Synopsys Stock Performance

NASDAQ SNPS opened at $448.38 on Wednesday. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33. The firm’s fifty day moving average price is $475.78 and its two-hundred day moving average price is $461.46. Synopsys has a 1 year low of $376.18 and a 1 year high of $651.73. The firm has a market capitalization of $85.86 billion, a P/E ratio of 103.79, a price-to-earnings-growth ratio of 2.67 and a beta of 1.22.

Synopsys (NASDAQ:SNPSGet Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.15 by $0.20. Synopsys had a net margin of 8.91% and a return on equity of 5.83%. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. During the same period in the prior year, the firm posted $3.67 earnings per share. The company’s quarterly revenue was up 41.9% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, research analysts anticipate that Synopsys will post 10.65 EPS for the current year.

Key Stories Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

Insider Buying and Selling at Synopsys

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the company’s stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the company’s stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer owned 75,020 shares in the company, valued at $34,431,179.20. This trade represents a 16.29% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by insiders.

Hedge Funds Weigh In On Synopsys

Several institutional investors and hedge funds have recently modified their holdings of SNPS. Sankala Group LLC acquired a new stake in Synopsys during the fourth quarter worth about $25,000. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys during the fourth quarter worth about $28,000. Caitong International Asset Management Co. Ltd acquired a new stake in Synopsys during the fourth quarter worth about $28,000. IMG Wealth Management Inc. acquired a new stake in Synopsys during the first quarter worth about $30,000. Finally, Atlas Capital Advisors Inc. acquired a new stake in Synopsys during the fourth quarter worth about $32,000. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Analyst Recommendations for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.